FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2027587346> ?p ?o ?g. }

• W2027587346 endingPage "14324" @default.
• W2027587346 startingPage "14318" @default.
• W2027587346 abstract "The function of the second protein tyrosine phosphatase domain (D2) in two-domain protein tyrosine phosphatases (PTP) is not well understood. In CD45, D2 can interact with the catalytic domain (D1) and stabilize its activity. Although D2 itself has no detectable catalytic activity, it can bind substrate and may influence the substrate specificity of CD45. To further explore the function of D2 in T cells, a full-length construct of CD45 lacking the D1 catalytic domain (CD45RABC-D2) was expressed in CD45+ and CD45− Jurkat T cells. In CD45− Jurkat T cells, CD45RABC-D2 associated with Lck but, unlike its active counterpart CD45RABC, did not restore the induction of tyrosine phosphorylation or CD69 expression upon T cell receptor (TCR) stimulation. Expression of CD45RABC-D2 in CD45+ Jurkat T cells resulted in its association with Lck, increased the phosphorylation state of Lck, and reduced T cell activation. TCR-induced tyrosine phosphorylation was delayed, and although MAPK phosphorylation and CD69 expression were not significantly affected, the calcium signal and IL2 production were severely reduced. This indicates that the non-catalytic domains of CD45 can interact with Lck in T cells. CD45RABC-D2 acts as a dominant negative resulting in an increase in Lck phosphorylation and a preferential loss of the calcium signaling pathway, but not the MAPK pathway, upon TCR signaling. This finding suggests that, in addition to their established roles in the initiation of TCR signaling, CD45 and Lck may also influence the type of TCR signal generated. The function of the second protein tyrosine phosphatase domain (D2) in two-domain protein tyrosine phosphatases (PTP) is not well understood. In CD45, D2 can interact with the catalytic domain (D1) and stabilize its activity. Although D2 itself has no detectable catalytic activity, it can bind substrate and may influence the substrate specificity of CD45. To further explore the function of D2 in T cells, a full-length construct of CD45 lacking the D1 catalytic domain (CD45RABC-D2) was expressed in CD45+ and CD45− Jurkat T cells. In CD45− Jurkat T cells, CD45RABC-D2 associated with Lck but, unlike its active counterpart CD45RABC, did not restore the induction of tyrosine phosphorylation or CD69 expression upon T cell receptor (TCR) stimulation. Expression of CD45RABC-D2 in CD45+ Jurkat T cells resulted in its association with Lck, increased the phosphorylation state of Lck, and reduced T cell activation. TCR-induced tyrosine phosphorylation was delayed, and although MAPK phosphorylation and CD69 expression were not significantly affected, the calcium signal and IL2 production were severely reduced. This indicates that the non-catalytic domains of CD45 can interact with Lck in T cells. CD45RABC-D2 acts as a dominant negative resulting in an increase in Lck phosphorylation and a preferential loss of the calcium signaling pathway, but not the MAPK pathway, upon TCR signaling. This finding suggests that, in addition to their established roles in the initiation of TCR signaling, CD45 and Lck may also influence the type of TCR signal generated. CD45 is a transmembrane two-domain protein tyrosine phosphatase (PTP) 1The abbreviations used are: PTP, protein tyrosine phosphatase; IL, interleukin; CD45RABC-D2, containing extracellular RABC isoform, transmembrane region, membrane proximal region, the second PTP domain, and carboxyl tail; FACS, fluorescence-activated cell sorter; PLC, phospholipase C; MAPK, mitogen-activated protein kinase; J+, Jurkat leukemia T cell line, clone E6.1 (CD45 positive); J−, Jurkat leukemia T cell line, clone 45.01 (CD45 negative); Ab, antibody; mAb, monoclonal antibody; IP3, inositol 1,4,5-trisphosphate; PVDF, polyvinylidene difluoride; TCR, T cell antigen receptor; HRP, horseradish peroxidase; FITC, fluorescein isothiocyanate; ERK, extracellular signal-regulated kinase; LAR, leukocyte antigen-related protein. expressed exclusively in leukocytes (reviewed in Refs. 1.Thomas M.L. Annu. Rev. Immunol. 1989; 7: 339-369Crossref PubMed Google Scholar, 2.Trowbridge I.S. Thomas M.L. Annu. Rev. Immunol. 1994; 12: 85-116Crossref PubMed Scopus (666) Google Scholar, 3.Johnson P. Maiti A. Ng D.H.W. Herzenberg L.A. Weir D.M. Herzenberg L.A. Blackwell C. Weir's Handbook of Experimental Immunology. 5th Ed. II. Blackwell Science, Inc., Malden, MA1997: 62.61Google Scholar, 4.Hermiston M.L. Xu Z. Weiss A. Annu. Rev. Immunol. 2003; 21: 107-137Crossref PubMed Scopus (667) Google Scholar). There are 21 transmembrane PTP in the human genome, and 12 have two domains (5.Alonso A. Sasin J. Bottini N. Friedberg I. Osterman A. Godzik A. Hunter T. Dixon J. Mustelin T. Cell. 2004; 117: 699-711Abstract Full Text Full Text PDF PubMed Scopus (1549) Google Scholar). The catalytic activity of CD45 and other transmembrane two-domain PTP, such as PTPα and LAR, resides primarily in the first membrane proximal PTP with little or no activity attributed to the second PTP domain, D2 (6.Walton K.M. Dixon J.E. Ann. Rev. Biochem. 1993; 62: 101-120Crossref PubMed Scopus (416) Google Scholar). In the case of CD45, the majority of data indicate that D2 is inactive (7.Felberg J. Johnson P. J. Biol. Chem. 1998; 273: 17839-17845Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar, 8.Johnson P. Ostergaard H.L. Wasden C. Trowbridge I.S. J. Biol. Chem. 1992; 267: 8035-8041Abstract Full Text PDF PubMed Google Scholar, 9.Streuli M. Krueger N.X. Thai T. Tang M. Saito H. EMBO J. 1990; 9: 2399-2407Crossref PubMed Scopus (270) Google Scholar). It lacks critical catalytic residues and cannot readily bind phosphotyrosine (10.Felberg J. Lefebvre D.C. Lam M. Wang Y. Ng D.H. Birkenhead D. Cross J.L. Johnson P. J. Biol. Chem. 2004; 279: 3455-3462Abstract Full Text Full Text PDF PubMed Scopus (15) Google Scholar). Two functions have been proposed for CD45-D2: 1) to interact with and stabilize the catalytic D1 domain of CD45 (7.Felberg J. Johnson P. J. Biol. Chem. 1998; 273: 17839-17845Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar, 11.Felberg J. Johnson P. Biochem. Biophys. Res. Comm. 2000; 271: 292-298Crossref PubMed Scopus (20) Google Scholar) and 2) to bind substrate and facilitate substrate recruitment (10.Felberg J. Lefebvre D.C. Lam M. Wang Y. Ng D.H. Birkenhead D. Cross J.L. Johnson P. J. Biol. Chem. 2004; 279: 3455-3462Abstract Full Text Full Text PDF PubMed Scopus (15) Google Scholar, 12.Kashio N. Matsumoto W. Parker S. Rothstein D.M. J. Biol. Chem. 1998; 273: 33856-33863Abstract Full Text Full Text PDF PubMed Scopus (51) Google Scholar). CD45 is required for T cell activation by constitutively dephosphorylating the negative regulatory tyrosine of Lck, Tyr505 (reviewed in Refs. 4.Hermiston M.L. Xu Z. Weiss A. Annu. Rev. Immunol. 2003; 21: 107-137Crossref PubMed Scopus (667) Google Scholar and 13.Chan A.C. Shaw A.S. Curr. Opin. Immunol. 1996; 8: 394-401Crossref PubMed Scopus (170) Google Scholar, 14.Alexander D.R. Semin. Immunol. 2000; 12: 349-359Crossref PubMed Scopus (127) Google Scholar, 15.Johnson P. Felberg J. Mod. Asp. Immunobiol. 2000; 1: 156-159Google Scholar). The restoration of T cell signaling by activated Lck in CD45− T cells (16.Duplay P. Alcover A. Fargeas C. Sekaly R.P. Branton P.E. J. Biol. Chem. 1996; 271: 17896-17902Abstract Full Text Full Text PDF PubMed Scopus (15) Google Scholar) and restoration of T cell development in the CD45 null mouse by expression of Lck Y505F (17.Seavitt J.R. White L.S. Murphy K.M. Loh D.Y. Perlmutter R.M. Thomas M.L. Mol. Cell. Biol. 1999; 19: 4200-4208Crossref PubMed Scopus (65) Google Scholar) support this finding. Dephosphorylation at Tyr505 creates a “primed” Lck molecule that can become activated upon TCR encounter with antigen, which initiates the signal transduction cascade by phosphorylating downstream substrates such as CD3ζ and ZAP-70 and leads to the activation of PLCγ-1, inositol 1,4,5-trisphosphate (IP3) generation, an increase in intracellular calcium, CD69 expression, and IL2 production (18.Mustelin T. Tasken K. Biochem. J. 2003; 371: 15-27Crossref PubMed Scopus (238) Google Scholar, 19.Mustelin T. Rahmouni S. Bottini N. Alonso A. Immunol. Rev. 2003; 191: 139-147Crossref PubMed Scopus (55) Google Scholar). However, in CD45−/- thymocytes and in some CD45− T cell lines, Lck is hyperphosphorylated at both the negative and autophosphorylation sites, suggesting that CD45 may also down-regulate Lck activity by dephosphorylating the autophosphorylation site (reviewed in Refs. 20.Ashwell J.D. D'Oro U. Immunol. Today. 1999; 20: 412-416Abstract Full Text Full Text PDF PubMed Scopus (83) Google Scholar and 21.Thomas M.L. Brown E.J. Immunol. Today. 1999; 20: 406-411Abstract Full Text Full Text PDF PubMed Scopus (161) Google Scholar). CD45 has also been implicated in down-regulating Src family kinase activity by negatively regulating integrin and CD44-mediated T cell adhesion (22.Shenoi H. Seavitt J. Zheleznyak A. Thomas M.L. Brown E.J. J. Immunol. 1999; 162: 7120-7127PubMed Google Scholar, 23.Li R.H. Wong N. Jabali M.D. Johnson P. J. Biol. Chem. 2001; 276: 28767-28773Abstract Full Text Full Text PDF PubMed Scopus (47) Google Scholar). Although Lck and, to a lesser extent, Fyn are considered major substrates for CD45 in T cells (reviewed in Refs. 24.Chan A.C. Desai D.M. Weiss A. Annu. Rev. Immunol. 1994; 12: 555-592Crossref PubMed Scopus (500) Google Scholar and 25.Weil R. Veillette A. Curr. Top. Microbiol. Immunol. 1996; 205: 63-87PubMed Google Scholar), other CD45 substrates may also exist such as TCRζ, ZAP-70 and Jak kinases (26.Furukawa T. Itoh M. Krueger N.X. Streuli M. Saito H. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 10928-10932Crossref PubMed Scopus (150) Google Scholar, 27.Mustelin T. Williams S. Tailor P. Couture C. Zenner G. Burn P. Ashwell J.D. Altman A. Eur. J. Immunol. 1995; 25: 942-946Crossref PubMed Scopus (62) Google Scholar, 28.Irie-Sasaki J. Sasaki T. Matsumoto W. Opavsky A. Cheng M. Welstead G. Griffiths E. Krawczyk C. Richardson C.D. Aitken K. Iscove N. Koretzky G. Johnson P. Liu P. Rothstein D.M. Penninger J.M. Nature. 2001; 409: 349-354Crossref PubMed Scopus (458) Google Scholar). Although CD45-D2 has no catalytic activity, it has been implicated in regulating TCR signaling. CD45, but not a CD45-LAR-D2 chimera, decreased CD3ζ phosphorylation levels and induced ZAP-70 phosphorylation and IL2 production upon TCR stimulation, suggesting that CD45-D2 was important for directing CD3ζ dephosphorylation and ZAP-70 phosphorylation (12.Kashio N. Matsumoto W. Parker S. Rothstein D.M. J. Biol. Chem. 1998; 273: 33856-33863Abstract Full Text Full Text PDF PubMed Scopus (51) Google Scholar). Mutation of residues within the unique acidic 19 amino acid insert in CD45-D2 resulted in increased calcium levels in one T cell line and sustained calcium influx after TCR stimulation in another cell line (29.Wang Y. Liang L.Z. Esselman W.J. J. Immunol. 2000; 164: 2557-2564Crossref PubMed Scopus (15) Google Scholar). However, in another study, calcium levels and MAPK activation were reduced when cells expressing the 19 amino acid deletion mutant were stimulated via the TCR (30.Greer S.F. Wang Y. Raman C. Justement L.B. J. Immunol. 2001; 166: 7208-7218Crossref PubMed Scopus (21) Google Scholar). CD45 can associate with Lck in T cells (31.Schraven B. Kirchgessner H. Gaber B. Samstag Y. Meuer S. Eur. J. Immunol. 1991; 21: 2469-2477Crossref PubMed Scopus (91) Google Scholar, 32.Koretzky G.A. Kohmetscher M. Ross S. J. Biol. Chem. 1993; 268: 8958-8964Abstract Full Text PDF PubMed Google Scholar), and in vitro studies indicate that there is a complex interaction occurring between both the catalytic and non-catalytic regions of Lck and CD45 (33.Lefebvre D.C. Felberg J. Cross J.L. Johnson P. Biochim. Biophys. Acta. 2003; 1650: 40-49Crossref PubMed Scopus (13) Google Scholar). CD45-D2 binds to the kinase domain of Lck in a phosphotyrosine-independent manner, and the region in Lck responsible for mediating this interaction, the subdomain X region of Lck, is implicated in facilitating substrate binding and promoting dephosphorylation (10.Felberg J. Lefebvre D.C. Lam M. Wang Y. Ng D.H. Birkenhead D. Cross J.L. Johnson P. J. Biol. Chem. 2004; 279: 3455-3462Abstract Full Text Full Text PDF PubMed Scopus (15) Google Scholar). Here, we wanted to evaluate the interaction between the noncatalytic domains of CD45 and Lck in T cells. Cell Lines and Transfectants—The human Jurkat leukemia T cell lines, clone E6.1 (CD45 positive, J+) and clone 45.01 (CD45 negative, J−), were purchased from American Type Culture Collection (ATCC, Manassas, VA) and maintained in RPMI 1640 medium (Invitrogen) supplemented with 10% fetal bovine serum, 2 mm l-glutamine, 1 mm sodium pyruvate, and 100 μg/ml streptomycin-penicillin. J+ and J− cell lines were transfected by electroporation with constructs encoding full-length mouse CD45RABC, mouse CD45RABC lacking residues 649–939 (mouse CD45RABC-D2), or the pBCMGSneo vector (34.Karasuyama H. Kudo A. Melchers F. J. Exp. Med. 1990; 172: 969-972Crossref PubMed Scopus (300) Google Scholar) as a control. Deletion of residues 649–939 essentially removes the catalytic D1 and PTP domain and the spacer region (7.Felberg J. Johnson P. J. Biol. Chem. 1998; 273: 17839-17845Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar). Thus, CD45RABC-D2 expresses the extracellular RABC isoform, the transmembrane region, the membrane-proximal region, the inactive second PTP domain, and carboxyl tail (residues 1–648 and 940–1268). Cells were selected using 0.5–1 mg/ml active G418 (Invitrogen), and mouse CD45 expression was analyzed by flow cytometry. Following four rounds of sorting on the FACSVantage (BD Biosciences) for high and comparable expression of mouse CD45, two independent clones from J+ and J− cells were selected for further analysis, clones J+D2.1 and J+D2.2 and clones J−D2.1 and J−D2.2. Antibodies—The monoclonal Abs T29/33 (mouse IgG, anti-human CD45) and I3/2 (rat IgG2b, anti-mouse CD45) were gifts from I. S. Trowbridge (35.Trowbridge I.S. J. Exp. Med. 1978; 148: 313-323Crossref PubMed Scopus (204) Google Scholar). OKT3 (mouse IgG, anti-human CD3), C305 (mouse IgM, κ, anti-human TCR β subunit), and MB4B4 (rat IgG2a, anti-mouse CD45, B exon) were from ATCC. Antibodies were purified from tissue culture supernatants using protein A- or G-Sepharose 4B beads according to standard procedures. Anti-Lck (rabbit anti-Lck antisera, R54 3B) and anti-CD45 (rabbit anti-CD45 cytoplasmic domain antisera, RO2.2) were generated as previously described (36.Ng D.H.W. Jabali M.D. Maiti A. Borodchak P. Harder K. Brocker T. Malissen B. Jirik F.R. Johnson P. Biochem. J. 1997; 327: 867-876Crossref PubMed Scopus (15) Google Scholar). Anti-phospho-p44/42 MAPK, E10 (mouse anti-human IgG1), was purchased from Cell Signaling (Beverly, MA). Polyclonal goat anti-rat IgG coupled to horseradish peroxidase (HRP) or fluorescein isothiocyanate (FITC) was purchased from Jackson Immunoresearch Laboratories (Bar Harbor, ME). Polyclonal goat anti-mouse IgG conjugated with FITC or HRP was purchased from Caltag Laboratories (Burlingame, CA) and Southern Biotech (Birmingham, AL) respectively. Phycoerythrin-coupled antihuman CD69 mAb (mouse IgG1 κ) was obtained from BD Biosciences. Protein A-conjugated HRP was purchased from Bio-Rad, and antiphosphotyrosine monoclonal Ab (4G10) was from Upstate Biotechnology (Lake Placid, NY). Flow Cytometry—Cells (5 × 105/sample) were incubated on ice for 20 min with 100 μl of tissue culture supernatants from anti-human CD45 (T29/33), anti-mouse CD45 (I3/2), anti-CD3 (OKT3), and anti-TCR (C305), washed, and then incubated with 100 μl of 1:100 FITC goat anti-mouse Ab or FITC goat anti-rat Ab. Alternatively, cells were incubated with 10 μl of 1:1 phycoerythrin-labeled CD69. After washing, a minimum of 5000 live cells were collected on a FACScan flow cytometer (BD Biosciences) and analyzed using CellQuest® software. Immunoprecipitation and Immunoblotting—Cells were lysed in either 1% Triton X-100 or 1% Brij-58 with 150 mm NaCl, 20 mm Tris-HCl (pH 7.5), 2 mm EDTA, 0.5 mm sodium orthovanadate, 0.2 mm sodium molybdate, 0.2 mm phenylmethylsulfonyl fluoride, 1 mg/ml leupeptin, 1 mg/ml aprotinin, and 1 mg/ml pepstatin (lysis buffer). Cell lysates were incubated on ice for 20 min and then centrifuged at 14,000 × g for 10 min at 4 °C. Detergent-soluble lysates were precleared by incubation with 20 μl of Sepharose CL 4B beads for 1 h at 4 °C. Mouse CD45 was immunoprecipitated from 1 × 107 cells lysed in 200 μl of 1% Triton X-100 lysis buffer with 35 μl of I3/2-coupled Sepharose beads (4 mg/ml) or from 3 × 107 cells lysed in 1% Brij-58 lysis buffer with 100 μl of I3/2 beads for Lck co-immunoprecipitation. Lck was immunoprecipitated from 1 × 106 cells lysed in 200 μl of 1% Triton X-100 lysis buffer and incubated with 20 μl of protein A-agarose beads from Repligen (Waltham, MA) precoupled with anti-Lck antiserum (R54 3B, 0.5 μl/sample). Immune complexes bound to beads were washed three times with lysis buffer. The beads were suspended in 10 μl of 3× SDS-PAGE sample-reducing buffer, boiled for 5 min, and then centrifuged at 14,000 × g for 3 min. Samples were analyzed on 7.5–10% acrylamide gels by SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membrane (Immobilon P, Millipore). Mouse CD45RABC was detected by Western blotting with tissue culture supernatants containing anti-mouse CD45RB mAb, MB4B4 (1:5), and mouse and human CD45 were detected by rabbit anti-CD45 cytoplasmic domain antisera, RO2.2 (1: 5000), and Lck was detected with rabbit R54 3B antisera (1:5000) along with the appropriate HRP-conjugated secondary Ab (1:5000). For analysis of the phosphorylation state of Lck, 4G10 (1:5000) was used with protein A-conjugated HRP. Blots were developed using ECL (Amersham Biosciences) and exposed to BioMax Film from Eastman Kodak Co. In co-immunoprecipitation experiments, Lck blots were stripped and reprobed with CD45RB antibody. Measurement of Calcium Mobilization—Calcium (Ca2+) mobilization was assayed in response to TCR cross-linking as described previously (37.Justement L.B. Wienands J. Hombach J. Reth M. Cambier J.C. J. Immunol. 1990; 144: 3272-3280PubMed Google Scholar). 5 × 106 cells in 1 ml of Buffer A (Dulbecco's modified Eagle's medium containing 10 mm HEPES (pH 7.0)) were loaded with the Ca2+ indicator dye Indo-1/AM (Molecular Probes, Eugene, OR) at a concentration of 5 μm and incubated at 37 °C for 30 min. 1 ml of Buffer B (Dulbecco's modified Eagle's medium containing 10 mm HEPES and 5% fetal calf serum (pH 7.4)) was added, and the cells were incubated at 37 °C for another 30 min. The cells were washed with Buffer C (Dulbecco's modified Eagle's medium containing 10 mm HEPES and 5% fetal calf serum (pH 7.2)) once and resuspended in Buffer C at a final concentration of 1 × 106/ml. Once a base line was taken, the analysis was paused, anti-TCR C305 was added to 50 μg/ml, and analysis was immediately resumed. Ionomycin (1 μm final concentration) was used as a control to confirm that cells responded equally to the influx of calcium. A FACSVantage cell sorter (BD Biosciences) was used to measure the fluorescence emissions from free and Ca2+-bound Indo-1/AM. Fluorescence emissions were separated by a 505-nm short pass beam splitter into component emissions by passage through 424- and 530-nm-centered 10-nm bandpass filters to detect violet and blue, respectively. Ratios of the emissions were calculated and plotted against time. IL2 Secretion—Cells (1 × 105) in 200 μl of RPMI 1640 medium containing 10% fetal calf serum were stimulated in flat bottom 96-well tissue culture plates with C305 (5–50 μg/ml) plus phorbol 12-myristate 13-acetate (PMA) (10 ng/ml, Sigma). IL2 secretion was determined after 12 h by enzyme-linked immunosorbent assay (BD Biosciences) performed in duplicate or triplicate. Cell Activation—For analysis of tyrosine and MAPK phosphorylation, 1–2 × 106 cells (in 20-μl volume) were stimulated with C305 (10 μg/sample) from 0 to 60 min at 37 °C. Unstimulated control samples were treated with C305 and lysed immediately. At various time points, reactions were placed on ice and 6 μl of 5× 1% Triton X-100 lysis buffer added. Cell lysates were centrifuged at 14,000 × g for 10 min at 4 °C. The supernatant was mixed with 3× SDS-PAGE reducing sample buffer, boiled, and centrifuged briefly. 2 × 105 cell equivalents were analyzed on 10% acrylamide gels and transferred to PVDF. The membranes were incubated with either anti-phosphotyrosine (4G10, 1:5000) or anti-phospho-ERK1/2 (E10, 1:1000), washed, and then incubated with goat anti-mouse-conjugated HRP (1:5000) and visualized using ECL. For analysis of CD69 expression after TCR stimulation, cells (5 × 105/sample) were suspended in 20 μl of media and stimulated with C305 (10 μg/sample) at 37 °C for 30 min or left untreated. Up to 1 ml of fresh media was added into each sample, and cells were incubated at 37 °C from 0 to 8 h. Cells were incubated with anti-human CD69-coupled phycoerythrin and analyzed by flow cytometry. Expression of CD45RABC-D2 in CD45− Jurkat T Cells Does Not Restore TCR Signaling Events—To determine whether CD45-D2 has functions that are independent of the catalytic domain, a construct expressing full-length mouse CD45RABC lacking the catalytic D1 domain (amino acids 649–939) was transfected into CD45− (J45.01) Jurkat T cells (see “Experimental Procedures” for details). Stable transfectants were sorted for high expression of mouse CD45 and, if required, also sorted to ensure comparable levels of TCR/CD3 expression among the untransfected cells, vector alone control, and the CD45RABC-D2 transfected cells. CD45RABC-D2-transfected cells were then cloned, and at least two clones were chosen for subsequent analysis (J−D2.1 and J−D2.2) (Fig. 1, A and B). Full-length CD45RABC was also transfected into CD45− Jurkat T cells. The levels of expression of mouse CD45, TCR, and CD3 were checked routinely by FACS analysis to ensure comparable levels of expression (Fig. 1A). In addition, the presence of human CD45 was monitored by FACS analysis as low levels of human CD45 had previously been reported in the J45.01 cells (38.Koretzky G.A. Picus J. Schultz T. Weiss A. Proc. Natl. Acad. Sci. U. S. A. 1991; 88: 2037-2041Crossref PubMed Scopus (331) Google Scholar) and were observed in this case (Fig. 1A). Fig. 1B demonstrates the expression of CD45RABC-D2 and CD45RABC in J− cells after immunoprecipitation of mouse CD45, separation on SDS-PAGE, transfer to PVDF membrane, and then immunoblotting with an anti-mouse CD45RB-specific antibody. In the CD45− Jurkat cells, Lck is hyperphosphorylated at the negative regulatory site and TCR stimulation does not occur (reviewed in Refs. 1.Thomas M.L. Annu. Rev. Immunol. 1989; 7: 339-369Crossref PubMed Google Scholar, 2.Trowbridge I.S. Thomas M.L. Annu. Rev. Immunol. 1994; 12: 85-116Crossref PubMed Scopus (666) Google Scholar, and 4.Hermiston M.L. Xu Z. Weiss A. Annu. Rev. Immunol. 2003; 21: 107-137Crossref PubMed Scopus (667) Google Scholar). Transfection of the full-length CD45RABC, but not CD45RABC-D2, restored the initial induction of tyrosine phosphorylation upon TCR stimulation (Fig. 1C). CD45RABC also restored the induction of expression of CD69 monitored from 2 to 8 h, whereas the expression of CD45RABC-D2 had no effect on CD69 expression, even when stimulation was prolonged to 24 h (data not shown). This is consistent with CD45RABC-D2 lacking protein tyrosine phosphatase activity. CD45RABC-D2 Associates with Lck in CD45− and CD45+ Jurkat T Cells and Results in Increased Lck Phosphorylation in the CD45+ Jurkat T Cells—Mouse CD45RABC-D2 was transfected into CD45+ (JE6.1) Jurkat T cells (J+), and cells were sorted for high levels of expression of CD45RABC-D2 and approximately equivalent levels of expression of human CD45, TCR, and CD3 compared with the levels of the parental line (J+). Flow cytometry indicates the expression of these molecules (Fig. 2A). Specific expression of transfected mouse CD45RABC-D2 was also confirmed by blotting for anti-mouse CD45RB in J+ cell lysates (Fig. 2B, upper panel). Cell lysates were also blotted with anti-CD45 cytoplasmic domain antisera that recognize both mouse and human CD45. 2J. Felberg and P. Johnson, unpublished data. This result shows the presence of endogenous human CD45 in J+ cells and J+ cells transfected with vector alone (J+V) and both human and transfected mouse CD45RABC-D2 in J+D2.1 and D2.2 cells (Fig. 2B, lower panel). The antisera detect primarily two CD45 isoforms in J+ and J+V cells that correspond to the lower molecular mass isoforms of CD45 (39.McKenney D.W. Onodera H. Gorman L. Mimura T. Rothstein D.M. J. Biol. Chem. 1995; 270: 24949-24954Abstract Full Text Full Text PDF PubMed Scopus (54) Google Scholar). Coincidentally, the transfected CD45RABC-D2 lacking D1 but expressing all three alternatively spliced exons (ABC) migrated to a similar position as the lower molecular mass isoform of endogenous CD45. Mouse CD45 was immunoprecipitated from 1% Brij-58 detergent-soluble lysates of CD45+ and CD45− cells, subjected to SDS-PAGE, and then immunoblotted for Lck. Fig. 3, A and B, shows that Lck co-immunoprecipitated with CD45RABC and CD45RABC-D2 in both the CD45+ and CD45− T cells. This demonstrates that CD45RABC-D2 can associate with Lck in the absence of endogenous CD45. It also suggests that the interaction occurs independently of Lck phosphorylation, because Lck is hyperphosphorylated in CD45− but not in the CD45+ cells (Fig. 3C). In addition, this shows that the association can occur in the absence of the active PTP domain, CD45-D1. Lck was immunoprecipitated from 1% Triton-X-100-soluble lysates and separated by 10% SDS-PAGE. The tyrosine phosphorylation state of Lck was analyzed by Western blotting with an anti-phosphotyrosine mAb, 4G10. Fig. 3C shows increased Lck phosphorylation in the Jurkat cells expressing CD45RABC-D2. A comparison of Lck phosphorylation in untransfected CD45+ and CD45− with that in CD45RABC-D2-transfected cells revealed that the phosphorylation was always greater than the level observed in the CD45+ cells but less than that observed in the CD45− Jurkat cells. In addition, the level of Lck phosphorylation was affected by the amount of CD45RABC-D2 expressed. At lower expression levels, less Lck was phosphorylated (data not shown). This finding suggests that the presence of CD45RABC-D2 is preventing normal Lck dephosphorylation in CD45+ Jurkat T cells. CD45RABC-D2 Does Not Affect MAPK Activation or CD69 Expression—To determine whether the presence of CD45RABC-D2 affected TCR signaling and T cell activation, the cells were stimulated with soluble TCR antibody. Cells expressing CD45RABC-D2 showed a slower induction of tyrosine-phosphorylated proteins (Fig. 4A). Maximum phosphorylation was observed in the parental CD45+ cells after 1 min, whereas comparable phosphorylation was not observed in the CD45RABC-D2-transfected cells until 5 min. To determine whether this change translated to any changes in downstream effects, MAPK (ERK1/2) phosphorylation and CD69 expression levels were monitored. Fig. 4B showed that, whereas MAPK phosphorylation was absent in the CD45− T cells and induced at 5 min in the CD45+ T cells, the presence of CD45RABC-D2 did not significantly affect the induction time or intensity of ERK1/2 phosphorylation. Because CD69 expression is downstream of MAPK activation (40.Testi R. D'Ambrosio D. De Maria R. Santoni A. Immunol. Today. 1994; 15: 479-483Abstract Full Text PDF PubMed Scopus (125) Google Scholar), we examined the induction of CD69 expression after TCR stimulation. Fig. 4C showed that the basal level of CD69 was slightly decreased in CD45RBAC-D2-expressing cells. There was also a slight delay of CD69 induction observed at 1 h, but by 2 h, CD69 induction was comparable. This observation suggests that the slight delay in the induction of tyrosine phosphorylation is insufficient to cause significant differences downstream in the MAPK pathway leading to CD69 expression. CD45RABC-D2 Prevents Calcium Flux and IL2 Production—To determine whether CD45RABC-D2 affected the other major signaling pathway in TCR signaling, the calcium pathway, cells were loaded with the fluorescent Ca2+ indicator dye, Indo-1/AM. Changes in intracellular calcium levels were monitored on the FACSVantage, and after a base line had been established, TCR antibody was added to the cells. Fig. 5A (upper panel) indicated that, although the CD45+ cells had a robust increase in intracellular calcium, cells expressing CD45RABC-D2 had virtually no calcium response. Their response was similar to Jurkat cells expressing no CD45 (J−). The addition of ionomycin (Fig. 5A, lower panel) led to similar increases in intracellular calcium, indicating that all of the cells were capable of responding to calcium. TCR signaling pathways in Jurkat T cells converge to stimulate IL2 gene transcription. To determine the outcome of TCR signaling in the CD45RABC-D2-transfected CD45+ T cells, cells were stimulated with TCR antibody together with PMA. The amount of IL2 secreted after 12 h of stimulation was measured by enzyme-linked immunosorbent assay. Fig. 5B indicated that the expression of CD45RABC-D2 dramatically reduced IL2 production in CD45+ Jurkat cells. A similar effect was also seen when the CD3 antibody, OKT3, and PMA were used for stimulation (data not shown). IL2 was not produced in the absence of CD45 or by PMA alone. CD45RABC-D2-transfected cells did not secrete significant levels of IL2, even after 48 h of stimulation (data not shown). This study indicates that a CD45 protein lacking the catalytic domain of CD45 can associate with Lck in T cells, independently of the phosphorylation state of Lck. Although the precise region of CD45 mediating this interaction was not determined, in vitro data indicate that the second PTP domain of CD45, D2, can bind directly to Lck in a phosphotyrosine-independent manner (10.Felberg J. Lefebvre D.C. Lam M. Wang Y. Ng D.H. Birkenhead D. Cross J.L. Johnson P. J. Biol. Chem. 2004; 279: 3455-3462Abstract Full Text Full Text PDF PubMed Scopus (15) Google Scholar). Furthermore, data from this study show that expression of CD45RABC-D2 results in an increase in Lck phosphorylation in CD45+ T cells, suggesting that, in the absence of an active D1, CD45RABC-D2 binds to Lck and prevents its dephosphorylation by endogenous CD45. This is also consistent with in vitro data showing a role for D2 in binding substrate and facilitating substrate dephosphorylation (10.Felberg J. Lefebvre D.C. Lam M. Wang Y. Ng D.H. Birkenhead D. Cross J.L. Johnson P. J. Biol. Chem. 2004; 279: 3455-3462Abstract Full Text Full Text PDF PubMed Scopus (15) Google Scholar). In addition, when CD45 D2 was replaced with LAR-D2 and the chimera was expressed in T cells, there was no decrease in CD3ζ phosphorylation, leading Kashio et al. (12.Kashio N. Matsumoto W. Parker S. Rothstein D.M. J. Biol. Chem. 1998; 273: 33856-33863Abstract Full Text Full Text PDF PubMed Scopus (51) Google Scholar) to conclude that CD45-D2 has a role in binding substrate. The data presented here are consistent with this conclusion as we show that CD45RABC-D2 binds to the major CD45 substrate in T cells, Lck. However, it is also possible that other regions of CD45 may facilitate an indirect interaction with Lck. For example, the extracellular domain of CD45, primarily CD45R0, has been reported to associate with CD4, which in turn binds Lck (41.Dornan S. Sebestyen Z. Gamble J. Nagy P. Bodnar A. Alldridge L. Doe S. Holmes N. Goff L.K. Beverley P. Szollosi J. Alexander D.R. J. Biol. Chem. 2002; 277: 1912-1918Abstract Full Text Full Text PDF PubMed Scopus (93) Google Scholar, 42.Leitenberg D. Novak T.J. Farber D. Smith B.R. Bottomly K. J. Exp. Med. 1996; 183: 249-259Crossref PubMed Scopus (102) Google Scholar). Although the transmembrane region of CD45 is not required for its association with Lck, it does mediate an interaction with CD45AP (43.Kitamura K. Maiti A. Ng D.H.W. Johnson P. Maizel A.L. Takeda A. J. Biol. Chem. 1995; 270: 21151-21157Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar), which also binds to Lck (44.Veillette A. Soussou D. Latour S. Davidson D. Gervais F.G. J. Biol. Chem. 1999; 274: 14392-14399Abstract Full Text Full Text PDF PubMed Scopus (23) Google Scholar). Although CD45RABC-D2 can associate with Lck in the absence of CD45, CD45RABC-D2 may also bind to CD45 because a small amount co-immunoprecipitated with endogenous CD45 (data not shown). This may also contribute to the reduced effectiveness of CD45, as it has been suggested that the membraneproximal region of one CD45 molecule may bind the catalytic domain of another and down-regulate its function (45.Desai D.M. Sap J. Schlessinger J. Weiss A. Cell. 1993; 73: 541-554Abstract Full Text PDF PubMed Scopus (246) Google Scholar, 46.Majeti R. Xu Z. Parslow T.G. Olson J.L. Daikh D.I. Killeen N. Weiss A. Cell. 2000; 103: 1059-1070Abstract Full Text Full Text PDF PubMed Scopus (225) Google Scholar). In Jurkat T cells, CD45 is required for the following TCR signaling events: the induction of tyrosine phosphorylation; PLCγ-1 activation; production of IP3, and increase in intracellular calcium levels (38.Koretzky G.A. Picus J. Schultz T. Weiss A. Proc. Natl. Acad. Sci. U. S. A. 1991; 88: 2037-2041Crossref PubMed Scopus (331) Google Scholar, 47.Koretzky G.A. Kohmetscher M.A. Kadleck T. Weiss A. J. Immunol. 1992; 149: 1138-1142PubMed Google Scholar). This positive effect on TCR signaling has been attributed to the ability of CD45 to dephosphorylate the negative regulatory tyrosine, Tyr505, in Lck, which generates a primed Lck that can be activated when the TCR recognizes antigen (reviewed in Refs. 4.Hermiston M.L. Xu Z. Weiss A. Annu. Rev. Immunol. 2003; 21: 107-137Crossref PubMed Scopus (667) Google Scholar, 15.Johnson P. Felberg J. Mod. Asp. Immunobiol. 2000; 1: 156-159Google Scholar, and 18.Mustelin T. Tasken K. Biochem. J. 2003; 371: 15-27Crossref PubMed Scopus (238) Google Scholar). In this study, CD45RABC-D2 disrupted the ability of endogenous CD45 to efficiently dephosphorylate Lck and resulted in aberrant TCR signaling. It caused a slight delay in the induction of tyrosine-phosphorylated proteins, but did not affect the tyrosine phosphorylation of MAPK or the induction of CD69 expression. However, it did have a dramatic effect on calcium flux and IL2 production. In other studies, deletion or mutation of the unique acidic region in CD45-D2 generated defects in calcium signaling and, in one case, MAPK activation in T cells (29.Wang Y. Liang L.Z. Esselman W.J. J. Immunol. 2000; 164: 2557-2564Crossref PubMed Scopus (15) Google Scholar, 30.Greer S.F. Wang Y. Raman C. Justement L.B. J. Immunol. 2001; 166: 7208-7218Crossref PubMed Scopus (21) Google Scholar) and when CD45-D2 was replaced with LAR-D2, TCR-induced IL2 production was reduced (12.Kashio N. Matsumoto W. Parker S. Rothstein D.M. J. Biol. Chem. 1998; 273: 33856-33863Abstract Full Text Full Text PDF PubMed Scopus (51) Google Scholar). Together, these data point toward a role for the noncatalytic D2 domain in regulating TCR signaling. Jurkat T cells and its associated T cell signaling mutants have been invaluable in identifying the components of the TCR signaling pathway (48.Abraham R.T. Weiss A. Nat. Rev. Immunol. 2004; 4: 301-308Crossref PubMed Scopus (400) Google Scholar). However, one caveat to the use of the Jurkat T cell line is that it is defective in the expression of two lipid phosphatases, SHIP and PTEN, that results in the constitutive activation of the phosphatidylinositol 3-kinase pathway. However, how this impacts TCR signaling events in this and other studies is not clear as the importance of phosphatidylinositol 3-kinase in TCR signaling is still poorly understood. TCR signaling activates at least two major signaling pathways leading to IL2 production, the Ras-MAPK pathway and the calcium pathway, and CD45 and Lck were thought to be required for both pathways. Indeed, CD45 is required for the activation and induction of tyrosine phosphorylation of PLCγ-1 (38.Koretzky G.A. Picus J. Schultz T. Weiss A. Proc. Natl. Acad. Sci. U. S. A. 1991; 88: 2037-2041Crossref PubMed Scopus (331) Google Scholar, 47.Koretzky G.A. Kohmetscher M.A. Kadleck T. Weiss A. J. Immunol. 1992; 149: 1138-1142PubMed Google Scholar), which generates diacylglycerol and IP3, and then IP3 triggers the release of calcium from intracellular stores (reviewed in Ref. 49.Lewis R.S. Annu. Rev. Immunol. 2001; 19: 497-521Crossref PubMed Scopus (709) Google Scholar). In addition, TCR-induced phosphorylation of MAPK was dependent on Src family kinase activation as PP2, a Src family kinase inhibitor, abolished its phosphorylation (data not shown). Here, we show that CD45RABC-D2 severely reduces the calcium signal but not the MAPK pathway, suggesting that the calcium pathway may have a higher threshold for activation than the MAPK pathway and thus may be more sensitive to changes in Lck activity. Alternatively, the activation of the MAPK pathway can occur through at least two mechanisms: 1) via PLCγ-1, diacylglycerol production, and Ras-GRP activation (50.Ebinu J.O. Stang S.L. Teixeira C. Bottorff D.A. Hooton J. Blumberg P.M. Barry M. Bleakley R.C. Ostergaard H.L. Stone J.C. Blood. 2000; 95: 3199-3203Crossref PubMed Google Scholar) and 2) by SOS, a Ras-GEF (guanine nucleotide exchange factor) that binds to Grb2, which is recruited to tyrosine-phosphorylated LAT upon TCR stimulation (reviewed in Refs. 51.Zhang W. Samelson L.E. Semin. Immunol. 2000; 12: 35-41Crossref PubMed Scopus (110) Google Scholar and 52.Cantrell D.A. Immunol. Rev. 2003; 192: 122-130Crossref PubMed Scopus (129) Google Scholar), and thus possibly be less affected by reduced Lck activity. Another possibility is that CD45RABCD2 may exert its effect independently of Lck. Exactly how CD45RABC-D2 is affecting the calcium pathway is not clear. If PLCγ-1 activity were reduced in CD45RABC-D2 expressing cells, one would predict a reduction in the Ras-GRP pathway leading to MAPK activation as well as a reduction in calcium signaling. However, there was no significant effect on ERK phosphorylation, even though this pathway is known to be activated upon TCR stimulation in Jurkat T cells (50.Ebinu J.O. Stang S.L. Teixeira C. Bottorff D.A. Hooton J. Blumberg P.M. Barry M. Bleakley R.C. Ostergaard H.L. Stone J.C. Blood. 2000; 95: 3199-3203Crossref PubMed Google Scholar, 53.Yablonski D. Kuhne M.R. Kadlecek T. Weiss A. Science. 1998; 281: 413-416Crossref PubMed Scopus (358) Google Scholar). Consistent with this finding, the expression of CD45RABC-D2 only slightly delayed the TCR-induced phosphorylation of PLCγ-1 (data not shown). This result suggests that the defect in the calcium signal may be downstream of PLCγ-1. The precise target affected by CD45RABC-D2 remains to be identified, but candidates are the IP3 receptor, which is tyrosinephosphorylated by the Src family kinase, Fyn, or T cell calcium channels, the regulation of which is poorly understood. Finally, the expression of CD45RABC-D2 dramatically affected the production of IL2 in response to TCR stimulation. This was via a major effect on the calcium pathway, not the Ras-MAPK pathway. Interestingly, defective calcium signals, but not MAPK signaling, upon TCR recognition are associated with the induction of adaptive tolerance in T cells (54.Schwartz R.H. Annu. Rev. Immunol. 2003; 21: 305-334Crossref PubMed Scopus (1132) Google Scholar). This study suggests that this type of signaling would occur upon TCR recognition if CD45 was prevented from effectively dephosphorylating Lck or if Lck phosphorylation became deregulated. We thank Dr. Ian Trowbridge for the gift of antibodies and Andy Johnson at the University FACS facility for sorting the cells and help with the calcium assays. We thank Dr. Jackie Felberg, Jacqueline Lai, Brian Ruffell, and Jennifer L. Cross for reading the manuscript." @default.
• W2027587346 created "2016-06-24" @default.
• W2027587346 creator A5009648508 @default.
• W2027587346 creator A5068559729 @default.
• W2027587346 date "2005-04-01" @default.
• W2027587346 modified "2023-09-26" @default.
• W2027587346 title "Expression of CD45 Lacking the Catalytic Protein Tyrosine Phosphatase Domain Modulates Lck Phosphorylation and T Cell Activation" @default.
• W2027587346 cites W136427227 @default.
• W2027587346 cites W1487845449 @default.
• W2027587346 cites W1496650340 @default.
• W2027587346 cites W1510860702 @default.
• W2027587346 cites W1578244808 @default.
• W2027587346 cites W1604234777 @default.
• W2027587346 cites W1606551122 @default.
• W2027587346 cites W1656644461 @default.
• W2027587346 cites W1920982543 @default.
• W2027587346 cites W1967234833 @default.
• W2027587346 cites W1970612654 @default.
• W2027587346 cites W1973717772 @default.
• W2027587346 cites W198906282 @default.
• W2027587346 cites W1989535960 @default.
• W2027587346 cites W1989578216 @default.
• W2027587346 cites W1989885576 @default.
• W2027587346 cites W1990693463 @default.
• W2027587346 cites W1996405135 @default.
• W2027587346 cites W1997546191 @default.
• W2027587346 cites W1998814673 @default.
• W2027587346 cites W2007828430 @default.
• W2027587346 cites W2019428712 @default.
• W2027587346 cites W2043617798 @default.
• W2027587346 cites W2043846834 @default.
• W2027587346 cites W2050207461 @default.
• W2027587346 cites W2053625020 @default.
• W2027587346 cites W2055600777 @default.
• W2027587346 cites W2056344762 @default.
• W2027587346 cites W2060368420 @default.
• W2027587346 cites W2061349114 @default.
• W2027587346 cites W2064426988 @default.
• W2027587346 cites W2065327238 @default.
• W2027587346 cites W2068162750 @default.
• W2027587346 cites W2070166919 @default.
• W2027587346 cites W2077229146 @default.
• W2027587346 cites W2077648546 @default.
• W2027587346 cites W2081282655 @default.
• W2027587346 cites W2087594396 @default.
• W2027587346 cites W2089725557 @default.
• W2027587346 cites W2108696099 @default.
• W2027587346 cites W2109495864 @default.
• W2027587346 cites W2110594269 @default.
• W2027587346 cites W2112506009 @default.
• W2027587346 cites W2129395959 @default.
• W2027587346 cites W2146703639 @default.
• W2027587346 cites W2152624886 @default.
• W2027587346 cites W2155308169 @default.
• W2027587346 cites W2160421139 @default.
• W2027587346 cites W2167620826 @default.
• W2027587346 cites W2172937773 @default.
• W2027587346 cites W2181131337 @default.
• W2027587346 doi "https://doi.org/10.1074/jbc.m413265200" @default.
• W2027587346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15687496" @default.
• W2027587346 hasPublicationYear "2005" @default.
• W2027587346 type Work @default.
• W2027587346 sameAs 2027587346 @default.
• W2027587346 citedByCount "14" @default.
• W2027587346 countsByYear W20275873462012 @default.
• W2027587346 countsByYear W20275873462015 @default.
• W2027587346 countsByYear W20275873462016 @default.
• W2027587346 countsByYear W20275873462017 @default.
• W2027587346 countsByYear W20275873462022 @default.
• W2027587346 crossrefType "journal-article" @default.
• W2027587346 hasAuthorship W2027587346A5009648508 @default.
• W2027587346 hasAuthorship W2027587346A5068559729 @default.
• W2027587346 hasBestOaLocation W20275873461 @default.
• W2027587346 hasConcept C11960822 @default.
• W2027587346 hasConcept C178666793 @default.
• W2027587346 hasConcept C185592680 @default.
• W2027587346 hasConcept C197153747 @default.
• W2027587346 hasConcept C2776165026 @default.
• W2027587346 hasConcept C2777553839 @default.
• W2027587346 hasConcept C55493867 @default.
• W2027587346 hasConcept C85528070 @default.
• W2027587346 hasConcept C86803240 @default.
• W2027587346 hasConcept C95444343 @default.
• W2027587346 hasConceptScore W2027587346C11960822 @default.
• W2027587346 hasConceptScore W2027587346C178666793 @default.
• W2027587346 hasConceptScore W2027587346C185592680 @default.
• W2027587346 hasConceptScore W2027587346C197153747 @default.
• W2027587346 hasConceptScore W2027587346C2776165026 @default.
• W2027587346 hasConceptScore W2027587346C2777553839 @default.
• W2027587346 hasConceptScore W2027587346C55493867 @default.
• W2027587346 hasConceptScore W2027587346C85528070 @default.
• W2027587346 hasConceptScore W2027587346C86803240 @default.
• W2027587346 hasConceptScore W2027587346C95444343 @default.
• W2027587346 hasIssue "14" @default.
• W2027587346 hasLocation W20275873461 @default.
• W2027587346 hasOpenAccess W2027587346 @default.
• W2027587346 hasPrimaryLocation W20275873461 @default.
• W2027587346 hasRelatedWork W1965518306 @default.

• next